Pharma for Obama, but neither candidate loves pharma

While drug companies have donated about $450,000 to the Obama campaign, they've only given McCain a little over $132,000.  Interestingly, this is the opposite of what we saw in the Bush-Kerry election, where the republican candidate received almost twice as much as the democrat.

For their parts, both candidates strongly support generics, including getting them to market faster and promoting their inclusion in trade agreements with developing countries. McCain and Obama both also support government negotiation of medications included in Medicare plans, re-importation and price controls - which neither big pharma nor biotech companies are likely to appreciate.  

- the story at Medical Marketing & Media
- see more at CNBC

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.